Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Biofermin Pharmaceutical. (4517.TSE) Q2 2019 Earnings
4517.TSE
24
Jul
Expected
Q3 2018
Q4 2018
Q1 2019
Q2 2019
31.79
37.82
43.84
49.87
Details
Expected EPS
N/A
Actual EPS
40.3156
Surprise EPS
40.32
Surprise Percent
+∞%
Description
Biofermin Pharmaceutical. (4517.TSE) has reported earnings of 40.3156 per share for Q2 2019.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist